UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062180
Receipt number R000071154
Scientific Title Evaluating Adjunctive Use of Toe Separators and Topical Clotrimazole in Interdigital Tinea Pedis Treatment: A Randomized Single Blind Controlled Trial
Date of disclosure of the study information 2026/07/08
Last modified on 2026/07/08 19:19:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Toe Separators for Interdigital Tinea Pedis Treatment

Acronym

TOE-TIP

Scientific Title

Evaluating Adjunctive Use of Toe Separators and Topical Clotrimazole in Interdigital Tinea Pedis Treatment: A Randomized Single Blind Controlled Trial

Scientific Title:Acronym

Evaluating Adjunctive Use of Toe Separators and Topical Clotrimazole in Interdigital Tinea Pedis Treatment: A Randomized Single Blind Controlled Trial (TOE-TIP)

Region

Asia(except Japan)


Condition

Condition

Interdigital Tinea Pedis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of adjunctive use of toe separators in combination with topical clotrimazole compared with topical clotrimazole alone in the treatment of interdigital tinea pedis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Treatment response at 6 weeks, classified as complete cure, partial cure, or treatment failure based on clinical assessment of signs and symptoms of interdigital tinea pedis.

Key secondary outcomes

* Resolution of itching
* Resolution of burning sensation
* Resolution of maceration
* Resolution of fissures
* Resolution of exudation
* Treatment adherence


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

* Type: Intervention
* Name: Toe separators plus topical clotrimazole
* Description: Participants will receive topical clotrimazole together with toe separators for 6 weeks.

Interventions/Control_2

* Type: Control
* Name: Topical clotrimazole alone
* Description: Participants will receive topical clotrimazole alone for 6 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

* Adults aged 18 to 70 years.
* Clinical diagnosis of interdigital tinea pedis (maceration, fissuring, exudation with itching, burning, or malodour, typically involving the 3rd-4th or 4th-5th interdigital spaces).
* Ability and willingness to provide written informed consent.

Key exclusion criteria

* Presence of other inflammatory foot conditions (e.g., pompholyx).
* Presence of non-interdigital forms of tinea pedis (vesiculobullous, moccasin, or ulcerative types).
* Current use of oral antifungal medication

Target sample size

102


Research contact person

Name of lead principal investigator

1st name Qurat
Middle name Ul ain
Last name Bangish

Organization

PAF HOSPITAL, FAZAIA POST GRADUATE MEDICAL INSTITUTE ISLAMABAD

Division name

DEPARTMENT OF DERMATOLOGY

Zip code

44000

Address

Department of Dermatology, PAF Hospital Islamabad, E-9, Islamabad, Pakistan

TEL

+923190533393

Email

quratulainbangish@gmail.com


Public contact

Name of contact person

1st name Qurat
Middle name Ul ain
Last name Bangish

Organization

PAF Hospital Islamabad, Fazaia Postgraduate Medical Institute

Division name

Department of Dermatology

Zip code

44000

Address

Department of Dermatology, PAF Hospital Islamabad, E-9, Islamabad, Pakistan

TEL

+923190533393

Homepage URL


Email

quratulainbangish@gmail.com


Sponsor or person

Institute

Fazaia PostGraduate Medical Institute
Department of Dermatology, PAF Hospital Islamabad.

Institute

Department

Personal name



Funding Source

Organization

No funding
Self-funded / Investigator-initiated

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Committee, Fazaia Postgraduate Medical Institute (FPGMI), Islamabad

Address

Ethical Review Committee, Fazaia Postgraduate Medical Institute, PAF Hospital Islamabad, E-9, Islamabad 44000, Pakistan

Tel

+92519566004

Email

FPGMI.ibd@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Department of Dermatology, PAF Hospital Islamabad (Islamabad)


Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 11 Month 01 Day

Date of IRB

2025 Year 11 Month 01 Day

Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2026 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 08 Day

Last modified on

2026 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071154